Literature DB >> 34021278

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Katie J Ewer1, Jordan R Barrett2, Sandra Belij-Rammerstorfer2, Adrian V S Hill2, Sarah C Gilbert2, Andrew J Pollard3, Teresa Lambe4, Hannah Sharpe2, Rebecca Makinson2, Richard Morter2, Amy Flaxman2, Daniel Wright2, Duncan Bellamy2, Mustapha Bittaye2, Christina Dold3, Nicholas M Provine5, Jeremy Aboagye2, Jamie Fowler2, Sarah E Silk2, Jennifer Alderson6, Parvinder K Aley3, Brian Angus5, Eleanor Berrie7, Sagida Bibi3, Paola Cicconi3, Elizabeth A Clutterbuck3, Irina Chelysheva3, Pedro M Folegatti2, Michelle Fuskova2, Catherine M Green7, Daniel Jenkin2, Simon Kerridge3, Alison Lawrie2, Angela M Minassian2, Maria Moore3, Yama Mujadidi3, Emma Plested3, Ian Poulton2, Maheshi N Ramasamy3, Hannah Robinson3, Rinn Song3, Matthew D Snape3, Richard Tarrant7, Merryn Voysey3, Marion E E Watson2, Alexander D Douglas2.   

Abstract

Entities:  

Year:  2021        PMID: 34021278     DOI: 10.1038/s41591-021-01363-0

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease.

Authors:  Denise Utami Putri; Chiou-Feng Lin; Ching-Sheng Hung; Chun-Kai Huang; Tsong-Yih Ou; Chun-Yi Lai; Po-Chun Tseng; Chung-Yi Cheng; Chih-Hsin Lee
Journal:  J Infect       Date:  2022-02-28       Impact factor: 38.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.